Copyright
©The Author(s) 2019.
World J Clin Cases. Oct 6, 2019; 7(19): 2995-3011
Published online Oct 6, 2019. doi: 10.12998/wjcc.v7.i19.2995
Published online Oct 6, 2019. doi: 10.12998/wjcc.v7.i19.2995
Table 3 Proton pump inhibitor therapeutic schemes used in the current literature
Drugs and duration | Study numbers |
4-5 wk | |
Omeprazole 40mg 1/d | 1 |
Omeprazole 20mg 1/d | 3 |
Omeprazole 40mg 2/d | 1 |
Esomeprazole 20mg 2/d | 2 |
Rabeprazole 10mg 1/d | 1 |
6-7 wk | |
Pantoprazole 40mg 2/d | 1 |
Pantoprazole 40mg 1/d | 2 |
Lansoprazole 30mg 2/d | 1 |
Omeprazole 20mg 2/d | 2 |
8-9 wk | |
Omeprazole 40mg 1/d | 1 |
Omeprazole 20mg 2/d | 1 |
Omeprazole 40mg 2/d | 1 |
Esomeprazole 40mg 2/d | 1 |
Esomeprazole 40mg 1/d | 2 |
Esomeprazole 20mg 2/d | 2 |
Esomeprazole 20mg 1/d | 1 |
Lansoprazole 30mg 2/d | 1 |
Lansoprazole 30mg 1/d | 2 |
Rabeprazole 20mg 1/d | 1 |
Rabeprazole 20mg 2/d | 1 |
Rabeprazole 10mg 1/d | 1 |
Pantoprazole 40mg 1/d | 2 |
12 wk | |
Omeprazole 40mg 1/d | 1 |
Omeprazole 20mg 3/d | 1 |
Omeprazole 20mg 2/d | 4 |
Omeprazole 20mg 1/d | 1 |
Esomeprazole 20mg 2/d | 3 |
Esomeprazole 40mg 2/d | 1 |
Lansoprazole 30mg 2/d | 4 |
Lansoprazole 15mg 2/d | 1 |
Rabeprazole 20mg 2/d | 1 |
Rabeprazole 10mg 1/d | 1 |
Pantoprazole 20 mg 2/d | 3 |
Pantoprazole 40 mg 1/d | 1 |
Pantoprazole 40 mg 2/d | 6 |
16-20 wk | |
Lansoprazole 30 mg 2/d | 2 |
Esomeprazole 40 mg 2/d | 1 |
Esomeprazole 40 mg 1/d | 1 |
Esomeprazole 20 mg 2/d | 1 |
Rabeprazole 20 mg 2/d | 1 |
Pantoprazole 40 mg 2/d | 1 |
Pantoprazole 40 mg 1/d | 1 |
24 wk | |
Omeprazole 20 mg 2/d | 2 |
Omeprazole 20 mg 1/d | 1 |
Lansoprazole 30 mg 2/d | 3 |
- Citation: Lechien JR, Mouawad F, Barillari MR, Nacci A, Khoddami SM, Enver N, Raghunandhan SK, Calvo-Henriquez C, Eun YG, Saussez S. Treatment of laryngopharyngeal reflux disease: A systematic review. World J Clin Cases 2019; 7(19): 2995-3011
- URL: https://www.wjgnet.com/2307-8960/full/v7/i19/2995.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v7.i19.2995